Huron consulting’s CEO Mark Hussey sells $4.04m in stock

Published 06/03/2025, 17:38
Huron consulting’s CEO Mark Hussey sells $4.04m in stock

Huron Consulting Group Inc. (NASDAQ:HURN), a company currently trading near its 52-week high with a remarkable 51% return over the past year according to InvestingPro data, saw its CEO and President Mark Hussey recently sell a significant portion of his shares. According to a Form 4 filing with the Securities and Exchange Commission, Hussey disposed of 27,672 shares of Huron stock on March 4, 2025. The shares were sold at prices ranging from $144.63 to $148.48, totaling approximately $4.04 million. The company, which InvestingPro analysis indicates is currently fairly valued, maintains a "GREAT" overall financial health score.

Following these transactions, Hussey retains ownership of 81,118 shares of Huron Consulting. The sales were conducted automatically under a Rule 10b5-1 trading plan, which was established in November 2024. The company has demonstrated strong momentum with a 41.6% price return over the past six months, and analysts maintain a bullish outlook with price targets reaching up to $180.

In other recent news, Huron Consulting Group announced impressive fourth-quarter 2024 financial results, surpassing analyst expectations. The company reported an earnings per share (EPS) of $1.90, significantly higher than the forecasted $1.52, and revenue of $399.31 million, exceeding the anticipated $379.99 million. For the full year 2024, Huron achieved record revenues of $1.49 billion, marking a 9.1% increase from the previous year, and a notable rise in net income to $116.6 million. Looking ahead, Huron’s 2025 guidance projects an EPS range of $6.80-$7.60 and revenue between $1.58 billion and $1.66 billion.

Analyst firms have responded positively to Huron’s performance. Truist Securities raised its price target for Huron to $180, maintaining a Buy rating, citing potential growth opportunities in healthcare and higher education due to regulatory changes. Benchmark analysts also increased their price target to $165, emphasizing the favorable macroeconomic environment in the healthcare sector. These updates reflect confidence in Huron’s ability to capitalize on evolving market conditions, particularly with expected changes in federal spending.

Huron’s strategic initiatives and acquisitions have bolstered its market position, with a focus on digital and managed services expansion. The company reported a substantial increase in free cash flow, allowing for debt reduction, share repurchases, and investments in Axia Consulting. Huron plans to provide further insights into its strategy and financial goals during an Investor Day scheduled for March 25, 2025.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.